Fiera Capital (Canada)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.9M | Sell |
64,369
-6,838
| -10% | -$3.84M | 0.12% | 126 |
|
|
2026
Q1 | $40M | Sell |
71,207
-26,553
| -27% | -$17M | 0.14% | 130 |
|
|
2025
Q4 | $66.1M | Sell |
97,760
-32,761
| -25% | -$22.3M | 0.21% | 90 |
|
|
2025
Q3 | $83.4M | Sell |
130,521
-3,577
| -3% | -$2.17M | 0.27% | 57 |
|
|
2025
Q2 | $71.9M | Sell |
134,098
-3,490
| -3% | -$1.67M | 0.24% | 63 |
|
|
2025
Q1 | $57.8M | Sell |
137,588
-3,610
| -3% | -$1.57M | 0.21% | 68 |
|
|
2024
Q4 | $58.4M | Buy |
141,198
+15,463
| +12% | +$6.78M | 0.18% | 77 |
|
|
2024
Q3 | $63.5M | Sell |
125,735
-38,574
| -23% | -$18.7M | 0.19% | 71 |
|
|
2024
Q2 | $80.1M | Buy |
164,309
+70
| +0% | +$35.1K | 0.25% | 61 |
|
|
2024
Q1 | $88.7M | Buy |
164,239
+37,606
| +30% | +$20.6M | 0.26% | 60 |
|
|
2023
Q4 | $70.3M | Buy |
126,633
+35,717
| +39% | +$16.8M | 0.22% | 65 |
|
|
2023
Q3 | $39.8M | Buy |
90,916
+5,844
| +7% | +$2.91M | 0.13% | 99 |
|
|
2023
Q2 | $42.7M | Buy |
85,072
+6,314
| +8% | +$3.03M | 0.12% | 100 |
|
|
2023
Q1 | $39.4M | Sell |
78,758
-2,803
| -3% | -$1.34M | 0.12% | 99 |
|
|
2022
Q4 | $33.3M | Sell |
81,561
-7,301
| -8% | -$2.83M | 0.1% | 104 |
|
|
2022
Q3 | $29M | Buy |
88,862
+5,549
| +7% | +$2.04M | 0.1% | 112 |
|
|
2022
Q2 | $29.2M | Buy |
83,313
+4,750
| +6% | +$1.94M | 0.09% | 120 |
|
|
2022
Q1 | $43M | Buy |
78,563
+26,920
| +52% | +$14.2M | 0.11% | 101 |
|
|
2021
Q4 | $34M | Buy |
51,643
+10,571
| +26% | +$6.64M | 0.08% | 138 |
|
|
2021
Q3 | $25.5M | Buy |
41,072
+39,105
| +1,988% | +$26.3M | 0.07% | 146 |
|
|
2021
Q2 | $1.24M | Buy |
+1,967
| New | +$1.09M | ﹤0.01% | 379 |
|
|
2021
Q1 | – | Sell |
-6,250
| Closed | -$3.12M | – | 622 |
|
|
2020
Q4 | $3.12M | Buy |
6,250
+25
| +0.4% | +$11.2K | 0.01% | 292 |
|
|
2020
Q3 | $2.45M | Sell |
6,225
-290
| -4% | -$107K | 0.01% | 299 |
|
|
2020
Q2 | $2.15M | Buy |
6,515
+5
| +0.1% | +$1.45K | 0.01% | 315 |
|
|
2020
Q1 | $1.58M | Sell |
6,510
-890
| -12% | -$232K | 0.01% | 356 |
|
|
2019
Q4 | $1.93M | Hold |
7,400
| – | – | 0.01% | 379 |
|
|
2019
Q3 | $2.01M | Buy |
7,400
+400
| +6% | +$111K | 0.01% | 351 |
|
|
2019
Q2 | $1.93M | Buy |
7,000
+1,900
| +37% | +$468K | 0.01% | 387 |
|
|
2019
Q1 | $1.14M | Sell |
5,100
-3,358
| -40% | -$693K | ﹤0.01% | 456 |
|
|
2018
Q4 | $1.57M | Buy |
8,458
+378
| +5% | +$77.5K | 0.01% | 416 |
|
|
2018
Q3 | $2.02M | Sell |
8,080
-1,695
| -17% | -$411K | 0.01% | 418 |
|
|
2018
Q2 | $2.13M | Buy |
9,775
+249
| +3% | +$51.3K | 0.01% | 406 |
|
|
2018
Q1 | $1.82M | Buy |
9,526
+156
| +2% | +$28.8K | 0.01% | 404 |
|
|
2017
Q4 | $1.47M | Buy |
9,370
+1,886
| +25% | +$297K | 0.01% | 409 |
|
|
2017
Q3 | $1.16M | Buy |
7,484
+1,466
| +24% | +$232K | 0.01% | 426 |
|
|
2017
Q2 | $971K | Sell |
6,018
-344,824
| -98% | -$56M | ﹤0.01% | 442 |
|
|
2017
Q1 | $54.2M | Sell |
350,842
-33,565
| -9% | -$4.63M | 0.29% | 71 |
|
|
2016
Q4 | $45.1M | Sell |
384,407
-75,425
| -16% | -$8.61M | 0.25% | 83 |
|
|
2016
Q3 | $51.8M | Sell |
459,832
-11,535
| -2% | -$1.22M | 0.29% | 80 |
|
|
2016
Q2 | $43.8M | Buy |
+471,367
| New | +$40.5M | 0.25% | 104 |
|
Other funds holding IDXX
Fiera Capital (Canada)'s IDXX Position: Q2 2026 in Review
Fiera Capital (Canada) reduced its Idexx Laboratories (IDXX) stake by 9.6% in Q2 2026, selling an estimated $3.84M and leaving 64,369 shares worth $33.9M. The position accounts for 0.12% of the portfolio, ranked #126.
Fiera Capital (Canada) first reported a position in IDXX in Q2 2016 and has held it in 40 quarters since. The position peaked at $88.7M in Q1 2024. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Fiera Capital (Canada) held 64,369 shares of Idexx Laboratories worth $33.9M as of Q2 2026.
- Fiera Capital (Canada) sold 6,838 Idexx Laboratories shares in Q2 2026, an estimated $3.84M.
- Idexx Laboratories made up 0.12% of Fiera Capital (Canada)'s portfolio in Q2 2026, its #126 holding.
- Fiera Capital (Canada) first reported a position in Idexx Laboratories in Q2 2016 and has held it in 40 quarters since.
- Fiera Capital (Canada)'s Idexx Laboratories position peaked at $88.7M in Q1 2024.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.